Scientific Papers

A maintenance hemodialysis patient complicated with hypogammaglobulinemia presenting typical COVID-19 pneumonia CT findings: a case report | Renal Replacement Therapy

Description of Image

  • Kikuchi K, Nangaku M, Ryuzaki M, Yamakawa T, Yoshihiro O, Hanafusa N, et al. Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study. Renal Replacement Therapy. 2020;6:55.


    Google Scholar
     

  • Hsu CM, Weiner DE, Aweh G, Miskulin DC, Manley HJ, Stewart C, Ladik V, et al. COVID-19 Among US Dialysis Patients: risk factors and outcomes from a National Dialysis Provider. Am J Kidney Dis. 2021;77:748–56.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Espi M, Charmetant X, Barba T, Mathieu C, Pelletier C, Koppe L, et al. A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis. Kidney Int. 2022;101:390–402.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sarkar A, Omar S, Alshareef A, Fanous K, Sarker S, Alroobi H, et al. The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: a systematic review. Hum Vaccin Immunother. 2023;19:2212568.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437–46.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399:1303–12.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mohsin M, Mahmud S. Omicron SARS-CoV-2 variant of concern: a review on its transmissibility, immune evasion, reinfection, and severity. Medicine (Baltimore). 2022;101:e29165.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Tsakok MT, Watson RA, Saujani SJ, Kong M, Xie C, Peschl H, et al. Reduction in chest CT severity and improved hospital outcomes in SARS-CoV-2 omicron compared with delta variant infection. Radiology. 2023;306:261–9.

    Article 
    PubMed 

    Google Scholar
     

  • Chiu MC, Li C, Liu X, Yu Y, Huang J, Wan Z, et al. A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 omicron variant. Cell Discov. 2022;8:57.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Alfi O, Hamdan M, Wald O, Yakirevitch A, Wandel O, Oiknine-Djian E, et al. SARS-CoV-2 omicron induces enhanced mucosal interferon response compared to other variants of concern, associated with restricted replication in human lung tissues. Viruses. 2022;14:1583.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Haruta M, Otsubo S, Otsubo Y. Characteristics of the 6th Japanese wave of COVID-19 in hemodialysis patients. Ren Replace Ther. 2022;8:61.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wen W, Cai S, Li Y, Wu X. Risk factors and prognosis for coronavirus disease 2019 among 131 hemodialysis patients during the Omicron variant epidemic. Ren Fail. 2023;45:2228924.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shi H, Han X, Jiang N, Cao Y, Alwalid O, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20:425–34.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhou S, Wang Y, Zhu T, Xia L. CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan. China AJR Am J Roentgenol. 2020;214:1287–94.

    Article 
    PubMed 

    Google Scholar
     

  • Han X, Chen J, Chen L, Jia X, Fan Y, Zheng Y, et al. Comparative analysis of clinical and CT findings in patients with SARS-CoV-2 original strain, delta and omicron variants. Biomedicines. 2023;11:901.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Crombé A, Bensid L, Seux M, Fadli D, Arnaud F, Benhamed A, et al. Impact of vaccination and the omicron variant on COVID-19-related chest CT findings: a multicenter study. Radiology. 2023;307:e222730.

    Article 
    PubMed 

    Google Scholar
     

  • Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol Pract. 2019;7:1763–70.

    Article 
    PubMed 

    Google Scholar
     

  • Weifenbach N, Jung A, Lötters S. COVID-19 infection in CVID patients: What we know so far. Immun Inflamm Dis. 2021;9(3):632–4.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ferenc T, Vilibić-Čavlek T. Common variable immunodeficiency: Predisposing or protective factor for severe complications of COVID-19? Acta Clin Croat. 2022;61:107–14.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Levavi H, Lancman G, Gabrilove J. Impact of rituximab on COVID-19 outcomes. Ann Hematol. 2021;100:2805–12.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nelson MC, Manos CK, Flanagan E, Prahalad S. COVID-19 after rituximab therapy in cSLE patients. Ther Adv Vaccines Immunother. 2023;11:25151355231181240.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ishio T, Tsukamoto S, Yokoyama E, Izumiyama K, Saito M, Muraki H, et al. Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma. Ann Hematol. 2023;102:1421–31.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhang-Sun J, Kirou RA, Kirou KA. Low peripheral B-cell counts in patients with systemic rheumatic diseases due to treatment with Belimumab and/or Rituximab are associated with low antibody responses to primary COVID-19 vaccination. HSS J. 2023;19:180–6.

    Article 
    PubMed 

    Google Scholar
     

  • Zhan H, Chen H, Liu C, Cheng L, Yan S, Li H, et al. Diagnostic value of D-dimer in COVID-19: a meta-analysis and meta-regression. Clin Appl Thromb Hemost. 2021;27:10760296211010976.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gubensek J, Lolic M, Ponikvar R, Buturovic-Ponikvar J. D-dimer levels in maintenance hemodialysis patients: High prevalence of positive values also in the group without predisposing diseases. Hemodial Int. 2016;20:198–203.

    Article 
    PubMed 

    Google Scholar
     

  • Butt B, Hussain T, Jarrar M, Khalid K, Albaker W, Ambreen A, et al. Efficacy and safety of remdesivir in COVID-19 Positive dialysis patients. Antibiotics (Basel). 2022;11:156.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lim JH, Park SD, Jeon Y, Chung YK, Kwon JW, Jeon YH, et al. Clinical effectiveness and safety of remdesivir in hemodialysis patients with COVID-19. Kidney Int Rep. 2022;7:2522–5.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Butt B, Hussain T, Jarrar M, Khalid K, Albaker W, Ambreen A, et al. Efficacy and safety of remdesivir in COVID-19 Positive dialysis patients. Antibiotics (Basel). 2022;11(2):156.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Shah MK, Parikh M, Prajapati D, Kute VB, Bhende P, Prajapati A, et al. Safety and tolerability of remdesivir in patients with end-stage renal disease on maintenance hemodialysis. Indian J Crit Care Med. 2022;26(5):619–25.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Description of Image

    Source link